Stock Events

Stock Events

Cymabay Therapeutics 

$32.48
267
+$0.01+0.03% Thursday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3JunExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2025
Q3 2025
Q4 2025
Next
-0.79
-0.54
-0.3
-0.05
Expected EPS
-0.05081178476
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
0Net Income

Analyst Ratings

$47.43Average Price Target
The highest estimate is 60.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
88%
Hold
13%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CBAY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
NextEra Energy
NEE
Mkt Cap169.52B
NextEra Energy, Inc. is a leading clean energy company, directly competing in the renewable energy sector with Via Renewables.
Duke Energy
DUK
Mkt Cap96.66B
Duke Energy Corporation operates in the electric power and gas distribution sectors, offering renewable energy solutions that compete with Via Renewables.
Southern Company
SO
Mkt Cap103.55B
Southern Company is involved in the generation and distribution of electricity, including renewable energy sources, making it a competitor.
Exelon
EXC
Mkt Cap46.58B
Exelon Corporation is a major player in the energy sector, with a significant focus on clean energy, competing with Via Renewables.
Dominion Energy
D
Mkt Cap50.09B
Dominion Energy, Inc. provides electricity and natural gas to customers, with a growing portfolio in renewable energy.
Public Service Enterprise Group
PEG
Mkt Cap40.21B
Public Service Enterprise Group Incorporated operates in the energy sector, with investments in renewable energy projects.
American Electric Power Company
AEP
Mkt Cap64.37B
American Electric Power Company, Inc. is a major electric utility company, with a focus on clean energy, including renewables.
Xcel Energy
XEL
Mkt Cap48.02B
Xcel Energy Inc. is an electric and natural gas utility company, with a strong emphasis on renewable energy sources.
AES
AES
Mkt Cap9.88B
The AES Corporation is a global power company, with a significant portion of its portfolio dedicated to renewable energy.
NRG Energy
NRG
Mkt Cap33.24B
NRG Energy, Inc. is an integrated power company, with operations in electricity generation, including renewable energy, competing with Via Renewables.

About

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.
Show more...
CEO
Sujal Shah
Employees
101
Country
US
ISIN
US23257D1037
WKN
000A116DD

Listings

F
DE
C0I.F
BOATS
BOATS
VIA.BOATS
XNYS
US
VIA

0 Comments

Share your thoughts

FAQ

What is Cymabay Therapeutics stock price today?▼
The current price of CBAY is $32.48 USD — it has increased by +0.03% in the past 24 hours. Watch Cymabay Therapeutics stock price performance more closely on the chart.
What is Cymabay Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cymabay Therapeutics stocks are traded under the ticker CBAY.
What is Cymabay Therapeutics revenue for the last year?▼
Cymabay Therapeutics revenue for the last year amounts to 0 USD.
What is Cymabay Therapeutics net income for the last year?▼
CBAY net income for the last year is 0 USD.
How many employees does Cymabay Therapeutics have?▼
As of April 02, 2026, the company has 101 employees.
In which sector is Cymabay Therapeutics located?▼
Cymabay Therapeutics operates in the Manufacturing sector.
When did Cymabay Therapeutics complete a stock split?▼
Cymabay Therapeutics has not had any recent stock splits.
Where is Cymabay Therapeutics headquartered?▼
Cymabay Therapeutics is headquartered in Newark, US.